Skip to search boxSkip to navigationSkip to main content

Neuraminidase inhibitors for influenza: Fully evaluating benefits and harms

  • Andreas Handel(corresponding author)
    ,
  • Mark H. Ebell
*Corresponding author for this work
Scholary Output:
Contribution to journal
Letter
Peer-review

Open access

Publication Information

Output type

Scholary Output:
Contribution to journal
Letter
Peer-review

Original language

English (US)

Pages from-to (Number of pages)

Pages e7-e8

Journal (Volume, Issue Number)

The Lancet Respiratory Medicine (Volume 3, Issue 3)

Publication milestones

  • Published - 03/01/2015

Publication status

Published - 03/01/2015

ISSN

2213-2600

Publication IDs

  • Scopus: 84924292591
  • PubMed: 25773218

Publication metrics

Metrics

SciVal
FWCI
0.43
SciVal
Author count
2
SciVal
citations
2
SciVal
Paper percentile
40
Fractional count
1
Fractional count
0.50
Fractional count
1
Fractional count
0.50
Fractional count
1
Fractional count
1
Scopus
citations

PlumX, opens in new tab

Citation count
2
Captures
7